# FDA Inspection 619025 - Lonza Biologics, Inc. - October 09, 2009

Source: https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/4d562007-a71f-41d6-a9e4-23da30915d84
Source feed: FDA_Inspections

> FDA Inspection 619025 for Lonza Biologics, Inc. on October 09, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 619025
- Company Name: Lonza Biologics, Inc.
- Inspection Date: 2009-10-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 832069 - 2013-05-02](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/d3411546-bc03-46d4-93ae-32d606cfcce2)
- [FDA Inspection 770753 - 2012-03-01](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/cfb45925-2780-4e99-98e4-1f8724cf8cec)
- [FDA Inspection 722282 - 2011-05-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/b8eadc5b-fc90-479a-9ae6-71b4b3001ab5)

Company: https://www.keypedia.com/companies/lonza-biologics-inc/65c37877-cae1-4065-aca5-ae3cddfb008a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d